The Business Cost of Menopause-Related Work Impairment
Beyond sick leave: what the data measures and what it misses
Sickness absence is the most visible indicator of workforce health. National statistics from the Netherlands show higher sick-leave rates among women, particularly in midlife age groups (40–60). However, occupational health research indicates that absence alone does not capture the full impact of menopause-related symptoms on work performance.
Research conducted with Centraal Bureau voor de Statistiek and Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek documents reduced work ability, increased fatigue, and emotional exhaustion among women in the menopausal transition. These findings coincide with the age window in which perimenopause and menopause occur.
Presenteeism and reduced work capacity
Occupational studies describe not only sickness absence but also reduced on-the-job performance. Women reporting menopausal symptoms demonstrate associations with:
lower perceived work ability
higher emotional exhaustion
reduced wellbeing at work
fatigue and sleep disruption
impaired concentration
In peer-reviewed research (Oude Hengel et al., 2023), symptom severity correlates with reduced work ability. Importantly, menopause is rarely recorded as the formal reason for absence. Complaints are often categorized under stress or general illness, which limits visibility in administrative systems.
This pattern suggests that the measurable effect extends beyond documented sick leave.
Organizational impact
When reduced work capacity affects a significant segment of midlife female employees, documented outcomes in the literature include:
increased sickness absence
decreased productivity
higher emotional strain
consideration of reducing working hours
contemplation of leaving employment
These effects are reported in Dutch workforce surveys and occupational health analyses. Because many affected employees hold experienced or senior roles, diminished work capacity may influence continuity and operational stability.
The research does not frame menopause as an isolated health event, but as a factor associated with workforce performance metrics.
Cost visibility and reporting limitations
Administrative HR data typically records absence duration but does not systematically capture menopause as a category. As a result:
symptom-related impairment may be recorded as burnout or stress
productivity loss without absence (presenteeism) remains unquantified
early disengagement may appear unrelated to health transition
Available Dutch data indicates that many women continue working while symptomatic and do not disclose hormone-related complaints. This contributes to underestimation of impact.
Conclusion
Dutch workforce statistics and occupational research indicate that menopause-related symptoms are associated with measurable reductions in work ability and increased sickness absence among women aged 40–60.
The economic effect includes both visible costs (absence) and less visible performance reductions (presenteeism).
For organizations, this establishes menopause as a workforce performance variable with operational and financial implications.
Sources
Centraal Bureau voor de Statistiek (CBS) – Menopausal employees experiencing work hindrance
https://www.cbs.nl/nl-nl/nieuws/2022/20/helft-werknemers-in-overgang-ondervindt-hinder-op-werk
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek + Centraal Bureau voor de Statistiek joint report – Hormone-related health complaints and impact on work
https://monitorarbeid.tno.nl/publicaties/hormoongerelateerde-gezondheidsklachten-bij-vrouwen-de-impact-op-werk/
Peer-reviewed study (Oude Hengel et al., 2023) – Perimenopause symptoms and work ability
https://pubmed.ncbi.nlm.nih.gov/37393659/
